Literature DB >> 26945216

Comparison of the Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Therapy on the Upper Trapezius in Myofascial Pain Syndrome: A Randomized Controlled Study.

Thusharika Dilrukshi Dissanayaka1, Ranjith Wasantha Pallegama, Hilari Justus Suraweera, Mark I Johnson, Anula Padma Kariyawasam.   

Abstract

OBJECTIVE: The aim of this study was to compare the effectiveness of transcutaneous electrical nerve stimulation and interferential therapy (IFT) both in combination with hot pack, myofascial release, active range of motion exercise, and a home exercise program on myofascial pain syndrome patients with upper trapezius myofascial trigger point.
DESIGN: A total of 105 patients with an upper trapezius myofascial trigger point were recruited to this single-blind randomized controlled trial. Following random allocation of patients to three groups, three therapeutic regimens-control-standard care (hot pack, active range of motion exercises, myofascial release, and a home exercise program with postural advice), transcutaneous electrical nerve stimulation-standard care and IFT-standard care-were administered eight times during 4 wks at regular intervals. Pain intensity and cervical range of motions (cervical extension, lateral flexion to the contralateral side, and rotation to the ipsilateral side) were measured at baseline, immediately after the first treatment, before the eighth treatment, and 1 wk after the eighth treatment.
RESULTS: Immediate and short-term improvements were marked in the transcutaneous electrical nerve stimulation group (n = 35) compared with the IFT group (n = 35) and the control group (n = 35) with respect to pain intensity and cervical range of motions (P < 0.05). The IFT group showed significant improvement on these outcome measurements than the control group did (P < 0.05).
CONCLUSION: Transcutaneous electrical nerve stimulation with standard care facilitates recovery better than IFT does in the same combination.

Entities:  

Mesh:

Year:  2016        PMID: 26945216     DOI: 10.1097/PHM.0000000000000461

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  6 in total

Review 1.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

2.  High-Energy Flux Density Extracorporeal Shock Wave Therapy Versus Traditional Physical Therapy Modalities in Myofascial Pain Syndrome: A Randomized-controlled, Single-Blind Trial.

Authors:  Ömer Gezgİnaslan; Sevgi GÜmÜŞ Atalay
Journal:  Arch Rheumatol       Date:  2019-06-25       Impact factor: 1.472

3.  Complementary and Alternative Modalities (CAM) for pain management in musculoskeletal diseases (MSDs).

Authors:  Debesh Bhoi; Dhruv Jain; Rakesh Garg; Karthikeyan P Iyengar; Wasimul Hoda; Raju Vaishya; Vijay Kumar Jain
Journal:  J Clin Orthop Trauma       Date:  2021-04-29

4.  A Novel Method for Muscle Elongation in Myalgia with Naqvi's-Dynamic Electrical Therapy Approach (DELTA)©: The First-Ever Case Report.

Authors:  Waqar M Naqvi; Maliha Fatima Quraishi; Sakshi P Arora; Chanan Goyal
Journal:  Cureus       Date:  2022-03-11

5.  Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain.

Authors:  Ana Luiza C Martimbianco; Gustavo Jm Porfírio; Rafael L Pacheco; Maria Regina Torloni; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12

6.  Photobiomodulation therapy and transcutaneous electrical nerve stimulation on chronic neck pain patients: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Érika Patrícia Rampazo; Ana Laura Martins de Andrade; Viviane Ribeiro da Silva; Cláudio Gregório Nuernberg Back; Richard Eloin Liebano
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.